The Amy Kim lab performs basic, translational, and clinical research on liver lesions and hepatocellular carcinoma (HCC). She uses state of the art techniques such artificial intelligence enhanced interpretation of pathology and imaging, as well as detection of circulating tumor cells for early detection and prediction of recurrence of HCC after resection and liver transplantation.